BRIEF published on 01/20/2025 at 07:35, 1 year 8 months ago POXEL Achieves Major Sales with TWYMEEG® in Japan Royalties TWYMEEG® Poxel Sumitomo Pharma Japan Sales
PRESS RELEASE published on 01/20/2025 at 07:30, 1 year 8 months ago Informations privilégiées / Autres communiqués Poxel annonce l'atteinte des 5 milliards de yens de ventes nettes de TWYMEEG® au Japon, entraînant des redevances croissantes et un paiement basé sur les ventes. Échéances de remboursement et perspective positive Japon Ventes Nettes Poxel TWYMEEG Redevances
PRESS RELEASE published on 01/20/2025 at 07:30, 1 year 8 months ago Inside Information / Other news releases Poxel to receive sales-based payment and higher royalties from Sumitomo Pharma in Q1 2025 for TWYMEEG® achieving JPY 5 billion net sales in Japan. Positive results expected beyond 2024 fiscal year Royalties Poxel Sumitomo Pharma TWYMEEG Sales-based Payment
BRIEF published on 12/23/2024 at 07:35, 1 year 9 months ago Poxel Releases Half-Year Financial Report for 2024 Financial Report 2024 Biopharmaceutical Poxel Audit Review
BRIEF published on 12/23/2024 at 07:35, 1 year 9 months ago Poxel publie son rapport financier semestriel pour 2024 Biopharmaceutique Rapport Financier 2024 Poxel Examen D'audit
PRESS RELEASE published on 12/23/2024 at 07:30, 1 year 9 months ago Half yearly financial reports and audit reports/limited reviews / Terms of availability of the half-yearly financial report Poxel SA announces availability of its 2024 half-year financial report, including condensed financial statements and activities for June 30, 2024 Biopharmaceutical Company Metabolic Disorders MASH 2024 Half-Year Financial Report Poxel SA
PRESS RELEASE published on 12/23/2024 at 07:30, 1 year 9 months ago Rapports financiers et d'audit semestriels/examens réduits / Modalités de mise à disposition du rapport financier semestriel POXEL SA annonce la mise à disposition de son rapport financier semestriel au 30 juin 2024, incluant comptes consolidés, rapport d'activité et attestation Euronext Biopharmaceutique Maladies Métaboliques Rapport Financier Semestriel Poxel SA
PRESS RELEASE published on 12/23/2024 at 07:30, 1 year 9 months ago Rapports financiers et d'audit semestriels/examens réduits / Rapport financier semestriel
BRIEF published on 12/09/2024 at 07:35, 1 year 9 months ago Poxel Announces Financial Challenges and Outlines Future Strategy Financial Results General Meeting Bonds Redemption Cash Runway Poxel SA
BRIEF published on 12/09/2024 at 07:35, 1 year 9 months ago Poxel annonce ses défis financiers et présente sa stratégie future Résultats Financiers Assemblée Générale Remboursement Des Obligations Poxel SA Piste De Trésorerie
Published on 09/25/2026 at 00:30, 1 hour 14 minutes ago Viemed Healthcare Announces Adoption of Automatic Securities Disposition Plan by President Michael Moore
Published on 09/25/2026 at 00:15, 1 hour 29 minutes ago CoTec Holdings Corp. Announces Extension of Private Placement of Unsecured Convertible Debentures
Published on 09/24/2026 at 22:01, 3 hours 43 minutes ago Fermi Selects CBRE to Operate and Maintain Its First Data Center
Published on 09/24/2026 at 14:55, 10 hours 49 minutes ago Nextech3D.ai Surpasses $1 Million in New Customer Contract Value, Expands AI Software Portfolio with KATE and Grows Multi-Year Enterprise Agreements
Published on 09/24/2026 at 20:29, 5 hours 15 minutes ago EQS-Adhoc: HelloFresh SE expects revenue for Q3 2026 below market expectations and adjusts outlook for the financial year 2026
Published on 09/24/2026 at 19:00, 6 hours 44 minutes ago HIAG provides a first-hand insight into its strategy and the added value it generates at its Capital Market Day
Published on 09/24/2026 at 18:40, 7 hours 3 minutes ago EQS-Adhoc: Brockhaus Technologies AG launches public share buyback offer of approx. €90 million for up to 3,592,000 shares
Published on 09/24/2026 at 18:15, 7 hours 29 minutes ago Epanko Value Engineering Identifies 20% Production Increase
Published on 09/24/2026 at 18:05, 7 hours 38 minutes ago DCK Tools Showcases Expanded Outdoor Power Equipment Lineup at Salonvert 2026
Published on 09/24/2026 at 18:31, 7 hours 12 minutes ago LNA SANTE : Mise à disposition du rapport financier semestriel 2026
Published on 09/24/2026 at 18:00, 7 hours 44 minutes ago GUILLEMOT CORPORATION: Availability of the interim financial report to June 30, 2026
Published on 09/24/2026 at 18:00, 7 hours 44 minutes ago GUILLEMOT CORPORATION : Mise à disposition du rapport financier semestriel au 30 juin 2026
